Synsam AB (publ) (STO:SYNSAM)
Sweden · Delayed Price · Currency is SEK 65.20
-1.30 (-1.95%)
At close: Dec 5, 2025
Synsam AB Revenue
Synsam AB had revenue of 1.73B SEK in the quarter ending September 30, 2025, with 11.03% growth. This brings the company's revenue in the last twelve months to 6.91B, up 10.03% year-over-year. In the year 2024, Synsam AB had annual revenue of 6.44B with 8.98% growth.
Revenue (ttm)
6.91B
Revenue Growth
+10.03%
P/S Ratio
1.35
Revenue / Employee
1.73M
Employees
3,739
Market Cap
9.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.44B | 530.00M | 8.98% |
| Dec 31, 2023 | 5.91B | 628.00M | 11.90% |
| Dec 31, 2022 | 5.28B | 608.00M | 13.02% |
| Dec 31, 2021 | 4.67B | 863.00M | 22.67% |
| Dec 31, 2020 | 3.81B | 65.40M | 1.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |